Star Sports Medicine Buys Back 16,850 H-Shares, Lifts Treasury Stock to 81,050 Units

Bulletin Express10-20 18:20

Star Sports Medicine Co., Ltd. (Hong Kong-listed, H-shares) disclosed that it repurchased 16,850 shares on 20 October 2026 via on-market transactions at prices ranging between HKD 59.50 and HKD 67.00. The outlay totalled HKD 1.02 million.

Following the buyback: • Issued shares outstanding (excluding treasury stock) declined by 0.03 % to 54.75 million. • Treasury shares increased from 64,200 to 81,050, while total issued shares remained unchanged at 54.83 million.

The transaction was executed under the share-repurchase mandate approved by shareholders on 26 June 2026, which authorises repurchases of up to 5.48 million shares. Cumulative repurchases since the mandate now stand at 81,050 shares, equivalent to 0.15 % of the company’s issued share capital on the mandate date.

Pursuant to Hong Kong listing rules, Star Sports Medicine is subject to a moratorium on new share issues or sales of treasury shares until 19 November 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment